{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-020591","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.269664+00:00","generated_at":"2026-06-01T03:54:24.830887+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Autonomix reports positive preliminary PoC trial results in pancreatic cancer pain patients; 60% responders","bullets":["60% of lead-in patients responded with mean 6.33 VAS pain reduction (8.0 to 1.67) at 7 days post-procedure.","No procedural complications or significant adverse events in the first five patients.","Responders reported 78% improvement in quality of health and 45% improvement in quality of life at 7 days.","Femoral access patients responded; brachial access did not; trial enrollment on track for year-end 2024.","Pain relief as quick as 1 day post-procedure; two patients succumbed to disease (expected, unrelated)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-020591","json":"https://secwatch.observer/filing/0001437749-24-020591.json","markdown":"https://secwatch.observer/filing/0001437749-24-020591.md","text":"https://secwatch.observer/filing/0001437749-24-020591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774924020591/0001437749-24-020591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774924020591/amix20240617_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T03:54:24.830887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}